These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3888516)

  • 21. Genetic vulnerability to schizophrenia.
    Murray RM; Reveley AM; McGuffin P
    Psychiatr Clin North Am; 1986 Mar; 9(1):3-16. PubMed ID: 3515330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte monoamine oxidase activity and chronic schizophrenia.
    DeLisi LE; Neckers LM; Staub RA; Zalcman SJ; Wyatt RJ
    Psychiatry Res; 1980 May; 2(2):179-86. PubMed ID: 6932061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Types of disease and models for their genetic analysis.
    Elston RC; Namboodiri KK
    Schizophr Bull; 1980; 6(2):368-74. PubMed ID: 6445588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine oxidase in schizophrenia: an overview.
    Wyatt RJ; Potkin SG; Bridge TP; Phelps BH; Wise CD
    Schizophr Bull; 1980; 6(2):199-207. PubMed ID: 7375851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors affecting the process of the recurrence of schizophrenia (a review)].
    Davtian SE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):115-20. PubMed ID: 1359721
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet monoamine oxidase activity and deficit syndrome schizophrenia.
    Samson JA; Gurrera RJ; Nisenson L; Schildkraut JJ
    Psychiatry Res; 1995 Jan; 56(1):25-31. PubMed ID: 7792339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia: some current neurochemical approaches.
    Rodnight R
    J Neurochem; 1983 Jul; 41(1):12-21. PubMed ID: 6345723
    [No Abstract]   [Full Text] [Related]  

  • 30. [The 'schizophrenic reaction'--a follow-up study after 20 years (author's transl)].
    Scharfetter C; Nüsperli M; Hurwitz E
    Arch Psychiatr Nervenkr (1970); 1979 Apr; 226(4):347-68. PubMed ID: 454148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom patterns related to somatosensory evoked response differences within a schizophrenic population.
    Shagass C; Soskis DA; Straumanis JJ; Overton DA
    Biol Psychiatry; 1974 Aug; 9(1):25-43. PubMed ID: 4457116
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet monoamine oxidase activity: relation to genetic load of schizophrenia.
    Baron M; Levitt M
    Psychiatry Res; 1980 Sep; 3(1):69-74. PubMed ID: 6934558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet monoamine oxidase values and genetic heterogeneity in schizophrenia research.
    Baron M; Levitt M; Perlman R
    JAMA; 1981 Sep; 246(13):1418-21. PubMed ID: 7265444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical processes in schizophrenia: an update.
    Bowers MB
    Schizophr Bull; 1980; 6(3):393-403. PubMed ID: 6996079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathways to schizophrenia: the impact of environmental factors.
    Howes OD; McDonald C; Cannon M; Arseneault L; Boydell J; Murray RM
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S7-S13. PubMed ID: 14972079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The functional basis for forms of schizophrenia (based on data from foreign studies). 3].
    Rogovin MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):765-74. PubMed ID: 4941430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.